$GNLX stock has now risen 10% today, according to our price data from Polygon. There has been approximately $1,329,534 of trading volume.
Here is what we see in our data on $GNLX (you can track the company live on Quiver's $GNLX stock page):$GNLX Insider Trading Activity
$GNLX insiders have traded $GNLX stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $GNLX stock by insiders over the last 6 months:
- THOMAS ZINDRICK (President and CEO) sold 10,764 shares for an estimated $31,430
- YONG YU (VP, Clinical Trial Operations) sold 5,579 shares for an estimated $16,290
- JOSEPH CAPPELLO (VP, Pharmaceutical Development) sold 4,737 shares for an estimated $13,832
- SEAN RYDER (General Counsel) sold 4,475 shares for an estimated $13,067
- RALPH SMALLING (Head of Regulatory) sold 1,259 shares for an estimated $3,676
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GNLX Hedge Fund Activity
We have seen 25 institutional investors add shares of $GNLX stock to their portfolio, and 33 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WOODWARD DIVERSIFIED CAPITAL, LLC added 317,173 shares (+21.7%) to their portfolio in Q2 2025, for an estimated $910,286
- HEIGHTS CAPITAL MANAGEMENT, INC removed 238,366 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $684,110
- MAI CAPITAL MANAGEMENT added 236,196 shares (+66161.3%) to their portfolio in Q2 2025, for an estimated $677,882
- GLOBAL RETIREMENT PARTNERS, LLC added 223,676 shares (+4473.5%) to their portfolio in Q2 2025, for an estimated $641,950
- MILLENNIUM MANAGEMENT LLC removed 211,473 shares (-90.5%) from their portfolio in Q2 2025, for an estimated $606,927
- VANGUARD GROUP INC added 176,895 shares (+13.9%) to their portfolio in Q2 2025, for an estimated $507,688
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 157,331 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $451,539
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$GNLX Analyst Ratings
Wall Street analysts have issued reports on $GNLX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- LUCID CAPITAL MARKETS issued a "Buy" rating on 07/21/2025
- Benchmark issued a "Speculative Buy" rating on 05/08/2025
To track analyst ratings and price targets for $GNLX, check out Quiver Quantitative's $GNLX forecast page.
$GNLX Price Targets
Multiple analysts have issued price targets for $GNLX recently. We have seen 2 analysts offer price targets for $GNLX in the last 6 months, with a median target of $16.5.
Here are some recent targets:
- Christopher Liu from LUCID CAPITAL MARKETS set a target price of $10.0 on 07/21/2025
- Bruce Jackson from Benchmark set a target price of $23.0 on 05/08/2025
You can track data on $GNLX on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
